Hims Hers Health is trading 6.5% up at $29.58 as shares rebound from last week’s sharp decline linked to an FTC health data privacy lawsuit.
- Investors are reassessing regulatory risks following the July 29, 2026, complaint involving alleged data-sharing and billing practices.
- Broader market strength is providing additional tailwinds, helping the stock recover a portion of the losses triggered by the recent legal action.